Annexon Biosciences IPO

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain.

Register for Details

For more details on financing and valuation for Annexon Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Annexon Biosciences's ticker symbol?


What is Annexon Biosciences's stock price?

2.99 as of 5/31/23

Learn more about Annexon Biosciences

Forge green plus iconForge green minus icon

What is Annexon Biosciences funding to date?

Annexon Biosciences has raised $154MM.
Forge green plus iconForge green minus icon

When was Annexon Biosciences founded?

Annexon Biosciences was founded in 2011.
Updated on: Jun 12, 2022